ÂÜÀòÂÒÂ×

Larry Liu is an experienced professional in the life sciences and medical technology sectors, currently serving as an Investor & Advisor at NyquistAI and Hubly Surgical, where contributions focus on advanced AI solutions and innovative surgical platforms, respectively. Liu's previous roles include strategic positions at Medable, Inc. and Johnson & Johnson, where efforts centered on decentralized clinical trials and digital surgery ecosystems. Additional experience includes regulatory affairs and strategic marketing at notable companies such as Stryker and Horizon Medical Device Consulting. Educational qualifications include a Bachelor of Science in Bioengineering from UC Berkeley and a Stanford Ignite certification in Innovation and Entrepreneurship from Stanford University.